- Stock: In Stock
- Brand: Square Pharmaceuticals
- Product ID: Fenofibrate
100% Secure Payment
Fenofibrate BP 160mg/tablet. 160mg x 30's pack: 150.00 MRP
INDICATION
Fenofibrate (fenofibrate capsules), micronised, is indicated as adjunctive
Fenofibrate
Fibrate
Lipired®
LIPID
MODIFYING
PREPARATIONS
LIPID
MODIFYING
PREPARATIONS
therapy to diet for treatment of hyperlipidemias of Type IIa, IIb, III, IV and V
who do not respond adequately to a determined dietary effort or other
appropriate measures to control them.
DOSAGE AND ADMINISTRATION
The dose is one 200 mg capsule per day. Dosage should be individualized according to patient response, and should be increased sequentially if necessary following repeat serum triglyceride estimations at 4 to 8 week intervals. Patients should be placed on an appropriate triglyceride-lowering diet before receiving fenofibrate, and should continue this diet during treatment with fenofibrate. Fenofibrate should be given with meals, thereby optimizing the bioavailability of the medication.
CONTRAINDICATION
1. Hepatic or severe renal dysfunction, including primary biliary cirrhosis,
and patients with unexplained persistent liver function abnormality.
2. Preexisting gallbladder disease.
3. Hypersensitivity to fenofibrate.
SPECIAL POPULATION
Geriatrics : This indicates that a similar dosage regimen can be used in the elderly, without increasing accumulation of the drug or metabolites. Pediatrics : No data are available. Fenofibrate is not indicated for use in the pediatric population.
Gender : No pharmacokinetic difference between male and female has been observed for fenofibrate. Renal insufficiency : The dosage of fenofibrate should be minimized in patients who have severe renal impairment, while no modification of dosage is required in patients having moderate renal impairment. Hepatic insufficiency : No pharmacokinetic study has been conducted in patients having hepatic insufficiency.
SIDE EFFECT
Digestive: hepatitis, cholelithiasis, cholecystitis, hepatomegaly Musculoskeletal: myalgia, myasthenia, rhabdomyolysis Skin and appendages: photosensitivity, eczema Cardiovascular: peripheral edema, angina, palpitations, tachycardia, and migraine